aica ribonucleotide has been researched along with Cancer of Prostate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azad, N; Iyer, AKV; Kaushik, V; Wright, C | 1 |
| Cheng, WC; Chiu, FY; Fang, SH; Hsieh, KL; Huang, KH; Huang, MY; Huang, SP; Li, CY; Lin, IL; Liu, PL; Su, CC; Yeh, HC | 1 |
| Gao, XH; Guo, F; Liu, SQ; Zhang, LY | 1 |
| Alekseyev, YO; Hu, GF; Huang, W; Ibaragi, S; Ido, Y; Lan, F; Lenburg, ME; Luo, Z; Tao, R; Wu, X; Zhou, J | 1 |
| Begg, AC; Haustermans, KM; Isebaert, SF; McBride, WH; Swinnen, JV | 1 |
| Engel, S; Milosevic, N; Sauer, H; Sharifpanah, F; Wartenberg, M | 1 |
| Ho, CT; Hung, CM; Lin, HY; Lin, JN; Liu, LC; Su, YH; Way, TD | 1 |
| Luo, Z; Ruderman, NB; Saha, AK; Wen, R; Xiang, X | 1 |
| Beckers, A; Brusselmans, K; De Schrijver, E; Deboel, L; Derua, R; Foufelle, F; Noël, A; Organe, S; Segers, J; Swinnen, JV; Timmermans, L; Van de Sande, T; Vanderhoydonc, F; Verhoeven, G; Waelkens, E | 1 |
| Carraway, RE; Hassan, S | 1 |
10 other study(ies) available for aica ribonucleotide and Cancer of Prostate
| Article | Year |
|---|---|
Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells.
Topics: Aminoimidazole Carboxamide; Apoptosis; Cell Line, Tumor; Cell Movement; G1 Phase Cell Cycle Checkpoints; Humans; Lactones; Male; Neoplasm Proteins; Orlistat; Prostatic Neoplasms; Reactive Oxygen Species; Resting Phase, Cell Cycle; Ribonucleotides | 2017 |
AICAR Induces Apoptosis and Inhibits Migration and Invasion in Prostate Cancer Cells Through an AMPK/mTOR-Dependent Pathway.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Drug Synergism; Epithelial-Mesenchymal Transition; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Ribonucleotides; Signal Transduction; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2019 |
AICAR induces AMPK-independent programmed necrosis in prostate cancer cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Male; Necrosis; Prostatic Neoplasms; Reactive Oxygen Species; Ribonucleotides; Treatment Outcome | 2016 |
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Gene Expression; Humans; Male; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Ribonucleotides | 2009 |
5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Gene Knockdown Techniques; Humans; Male; Metabolism; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Reactive Oxygen Species; Ribonucleosides; Ribonucleotides; RNA, Small Interfering; Time Factors; Tumor Stem Cell Assay | 2011 |
Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Caspase 3; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Enzyme Activators; Humans; JNK Mitogen-Activated Protein Kinases; Male; Phosphorylation; Prostatic Neoplasms; Reactive Oxygen Species; Ribonucleotides; TOR Serine-Threonine Kinases | 2012 |
Demethoxycurcumin modulates prostate cancer cell proliferation via AMPK-induced down-regulation of HSP70 and EGFR.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antineoplastic Agents, Phytogenic; Caspase 3; Cell Line, Tumor; Cell Proliferation; Curcuma; Curcumin; Diarylheptanoids; Down-Regulation; ErbB Receptors; Fatty Acid Synthase, Type I; HSP70 Heat-Shock Proteins; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-cbl; Ribonucleotides | 2012 |
AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Cell Division; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; Hypoglycemic Agents; Male; Multienzyme Complexes; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Ribonucleotides; Rosiglitazone; Thiazolidinediones | 2004 |
Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype.
Topics: Adenosine Monophosphate; Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Biomimetic Materials; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Cell Survival; Energy Metabolism; Female; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Ribonucleosides; Ribonucleotides; Xenograft Model Antitumor Assays | 2005 |
Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress.
Topics: Adenosine Triphosphate; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Blotting, Western; Cell Line, Tumor; DNA; Enzyme Activation; Enzyme Inhibitors; Humans; Inositol Phosphates; Kinetics; Male; Multienzyme Complexes; Neurotensin; Prostatic Neoplasms; Protein Binding; Protein Serine-Threonine Kinases; Receptors, Neurotensin; Ribonucleotides; Signal Transduction; Stress, Physiological | 2007 |